I International: Top News And Analysis Guest Dec 22, 2025 #1 The approval gives Novo Nordisk a head start over chief rival Eli Lilly, which is racing to launch its own obesity pill. Continue reading...
The approval gives Novo Nordisk a head start over chief rival Eli Lilly, which is racing to launch its own obesity pill. Continue reading...